Information:
Fel:
ID
23994
Beskrivning
Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus; ODM derived from: https://clinicaltrials.gov/show/NCT00530309
Länk
https://clinicaltrials.gov/show/NCT00530309
Nyckelord
Versioner (1)
- 2017-07-20 2017-07-20 -
Uppladdad den
20 juli 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Type 2 Diabetes Mellitus NCT00530309
Eligibility Type 2 Diabetes Mellitus NCT00530309
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes Mellitus NCT00530309
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
type 2 diabetes mellitus diagnosed at least 3 months with fpg level <=240mg/dl and hba1c between 6.5% and 10% inclusive.
boolean
C0011860 (UMLS CUI [1,1])
C0019018 (UMLS CUI [1,2])
C0019018 (UMLS CUI [1,2])
ID.2
Item
must be diet controlled - or - taking a single oral antidiabetic agent (other than thiazolidinediones) and willing to withdraw from this treatment from 2 weeks prior to the study.
boolean
C0743195 (UMLS CUI [1,1])
C0935929 (UMLS CUI [1,2])
C0935929 (UMLS CUI [1,2])
ID.3
Item
must have a bmi:<=35kg/m2, 20 to 70 years of age inclusive.
boolean
C1305855 (UMLS CUI [1])
ID.4
Item
woman must be of non-childbearing potential.
boolean
C0032961 (UMLS CUI [1])
ID.5
Item
positive test result for either syphilis, hbs antigen, hcv antibody, hiv antigen/antibody, or htlv-1 antibody.
boolean
C0039128 (UMLS CUI [1,1])
C0019168 (UMLS CUI [1,2])
C0166049 (UMLS CUI [1,3])
C0369498 (UMLS CUI [1,4])
C0019683 (UMLS CUI [1,5])
C0020095 (UMLS CUI [1,6])
C0019168 (UMLS CUI [1,2])
C0166049 (UMLS CUI [1,3])
C0369498 (UMLS CUI [1,4])
C0019683 (UMLS CUI [1,5])
C0020095 (UMLS CUI [1,6])
ID.6
Item
clinically significant hepatic enzyme elevation.
boolean
C0235996 (UMLS CUI [1])
ID.7
Item
history of metabolic disease other than t2dm.
boolean
C0025517 (UMLS CUI [1])
ID.8
Item
previous use of insulin as a treatment for diabetes within 3 months.
boolean
C0557978 (UMLS CUI [1])
ID.9
Item
history of severe gastrointestinal disease.
boolean
C0017178 (UMLS CUI [1])
ID.10
Item
clinically significant cardiovascular disease.
boolean
C0007222 (UMLS CUI [1])
ID.11
Item
significant renal disease as defined by screening lab test.
boolean
C0022658 (UMLS CUI [1])
ID.12
Item
history of drug (including albumin or albumin containing agents) allergy.
boolean
C0013182 (UMLS CUI [1])
ID.13
Item
history of alcohol or drug abuse.
boolean
C0085762 (UMLS CUI [1,1])
C0013146 (UMLS CUI [1,2])
C0013146 (UMLS CUI [1,2])
ID.14
Item
donation of blood in excess of 400ml within previous 4 months.
boolean
C0005794 (UMLS CUI [1])
ID.15
Item
previously received any glp-1 mimetic or any other albumin-containing products.
boolean
C0061355 (UMLS CUI [1,1])
C0001924 (UMLS CUI [1,2])
C0001924 (UMLS CUI [1,2])